Abstract
The epidemic of poliomyelitis that is prevailing at the present time so extensively in New York and in some degree widely throughout the United States has led to many inquiries being made regarding the serum treatment of the disease, and particularly of the stage to which the treatment has advanced. This brief paper is intended not only to answer such inquiries, but also to provide a basis for the wider employment of the treatment where the difficult conditions surrounding the obtaining of immune human serum can be surmounted. It was demonstrated by Flexner and Lewis, 1 and afterward confirmed by several investigators, that monkeys which had recovered from an attackof poliomyelitis induced experimentally were not subject to successful reinoculation with the virus of the disease. This was followed by the detection by Romer and Joseph 2 and later by others in the blood of such resistant or protected monkeys, and
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
